« Return to News | CROs/Service Providers | Study Conduct

BBK Creates New Global Mobilization Team Division

Tuesday, June 19, 2007 08:34 AM

Newton, Mass.-based patient recruitment company BBK Worldwide has created a new company division called the global mobilization team. The company stated that this division will help address the challenges of planning and deploying of resources for large-scale, global trials. BBK stated the division will include in-country staff with expertise in local patient recruitment, a web-based communication structure and real-time access to data essential for making changes in recruitment operations mid-trial.

"At one time, site support specialists were perceived as 'nice-to-haves,' until the industry realized that they made a big difference in enrollment, and then site support became standard practice. With the number of multinational trials on the rise, creating a sub-specialty in global mobilization is not just a nice thing to do - it's an industry imperative," stated Bonnie Brescia, co-founder and principal at BBK.

Waltham, Mass.-based CRO Parexel made a similar announcement about launching a global recruitment team called START – or Start-up and Accelerated Recruitment Team – which will use the company’s planning and recruitment tool called SPARC – or Scenario Planning and Recruitment Calculator.

 


 

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.